Cipher Historical Cash Flow
| CPH Stock | CAD 13.32 0.29 2.13% |
Analysis of Cipher Pharmaceuticals cash flow over time is an excellent tool to project Cipher Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Free Cash Flow of 19.1 M or Begin Period Cash Flow of 17.6 M as it is a great indicator of Cipher Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Cipher Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cipher Pharmaceuticals is a good buy for the upcoming year.
Cipher |
About Cipher Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Cipher balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cipher's non-liquid assets can be easily converted into cash.
Cipher Pharmaceuticals Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Cipher Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Cipher Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Cipher Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cipher Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cipher Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Cipher Pharmaceuticals' Change To Account Receivables is very stable compared to the past year. As of the 6th of February 2025, Change To Operating Activities is likely to grow to about 120.8 K, though Change In Working Capital is likely to grow to (3.6 M).
Cipher Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Cipher Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cipher Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 2.8M | 11.4M | 8.3M | 11.0M | 12.6M | 13.3M | |
| Free Cash Flow | 10.9M | 13.8M | 10.5M | 15.9M | 18.2M | 19.1M | |
| Change In Working Capital | 1.7M | 4.7M | (3.0M) | (3.3M) | (3.8M) | (3.6M) | |
| Begin Period Cash Flow | 6.3M | 9.1M | 20.5M | 28.8M | 33.2M | 17.6M | |
| Other Cashflows From Financing Activities | (125K) | 75K | 132K | 426K | 383.4K | 565.5K | |
| Depreciation | 1.2M | 701K | 989K | 1.2M | 1.4M | 1.4M | |
| Other Non Cash Items | 5.7M | 652K | (109K) | (788K) | (906.2K) | (860.9K) | |
| Capital Expenditures | 1.3M | 760K | 81K | 144K | 165.6K | 157.3K | |
| Total Cash From Operating Activities | 11.7M | 13.8M | 10.6M | 16.0M | 18.4M | 19.3M | |
| Net Income | 4.4M | 7.8M | 26.6M | 20.4M | 23.4M | 24.6M | |
| Total Cash From Financing Activities | (8.1M) | (2.5M) | (1.9M) | (5.2M) | (4.7M) | (4.5M) | |
| End Period Cash Flow | 9.1M | 20.5M | 28.8M | 39.8M | 45.8M | 48.1M | |
| Stock Based Compensation | 122K | 139K | 403K | 1.2M | 1.1M | 556.9K | |
| Change To Account Receivables | (342K) | 2.6M | (144K) | 1.7M | 2.0M | 2.1M | |
| Sale Purchase Of Stock | (78K) | (1.7M) | (2.0M) | (5.6M) | (5.0M) | (4.8M) | |
| Change To Inventory | 151K | (758K) | (502K) | (830K) | (747K) | (709.7K) | |
| Net Borrowings | (9.9M) | (7.9M) | (828K) | (58K) | (52.2K) | (49.6K) | |
| Total Cashflows From Investing Activities | (24.5M) | (1.5M) | (760K) | (81K) | (93.2K) | (97.8K) | |
| Change To Operating Activities | 53K | (95K) | 374K | 100K | 115K | 120.8K | |
| Change To Netincome | 4.1M | 4.2M | 677K | (14.0M) | (12.6M) | (12.0M) | |
| Change To Liabilities | (2.0M) | 2.0M | (1.1M) | (1.6M) | (1.5M) | (1.4M) | |
| Investments | (760K) | 0.0 | (81K) | (144K) | (165.6K) | (173.9K) |
Pair Trading with Cipher Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cipher Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Cipher Stock
The ability to find closely correlated positions to Cipher Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cipher Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cipher Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cipher Pharmaceuticals to buy it.
The correlation of Cipher Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cipher Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cipher Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cipher Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Cipher Stock
The Cash Flow Statement is a financial statement that shows how changes in Cipher balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cipher's non-liquid assets can be easily converted into cash.